BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 22570280)

  • 1. Conversion of arterial input functions for dual pharmacokinetic modeling using Gd-DTPA/MRI and 18F-FDG/PET.
    Poulin E; Lebel R; Croteau E; Blanchette M; Tremblay L; Lecomte R; Bentourkia M; Lepage M
    Magn Reson Med; 2013 Mar; 69(3):781-92. PubMed ID: 22570280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of the reference region method for dual pharmacokinetic modeling using Gd-DTPA/MRI and (18) F-FDG/PET.
    Poulin É; Lebel R; Croteau É; Blanchette M; Tremblay L; Lecomte R; Bentourkia M; Lepage M
    Magn Reson Med; 2015 Feb; 73(2):740-8. PubMed ID: 24604379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blind estimation of the arterial input function in dynamic contrast-enhanced MRI using purity maximization.
    Lin YC; Chan TH; Chi CY; Ng SH; Liu HL; Wei KC; Wai YY; Wang CC; Wang JJ
    Magn Reson Med; 2012 Nov; 68(5):1439-49. PubMed ID: 22383386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of model-based arterial input functions for dynamic contrast-enhanced MRI in tumor bearing rats.
    McGrath DM; Bradley DP; Tessier JL; Lacey T; Taylor CJ; Parker GJ
    Magn Reson Med; 2009 May; 61(5):1173-84. PubMed ID: 19253360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcompartmentalization of extracellular extravascular space (EES) into permeability and leaky space with local arterial input function (AIF) results in improved discrimination between high- and low-grade glioma using dynamic contrast-enhanced (DCE) MRI.
    Sahoo P; Rathore RK; Awasthi R; Roy B; Verma S; Rathore D; Behari S; Husain M; Husain N; Pandey CM; Mohakud S; Gupta RK
    J Magn Reson Imaging; 2013 Sep; 38(3):677-88. PubMed ID: 23390002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volumetry of [(11)C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme.
    Galldiks N; Ullrich R; Schroeter M; Fink GR; Jacobs AH; Kracht LW
    Eur J Nucl Med Mol Imaging; 2010 Jan; 37(1):84-92. PubMed ID: 19662410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
    Mendichovszky IA; Cutajar M; Gordon I
    Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reference region-based pharmacokinetic modeling in quantitative dynamic contract-enhanced MRI allows robust treatment monitoring in a rat liver tumor model despite cardiovascular changes.
    Steingoetter A; Svensson J; Kosanke Y; Botnar RM; Schwaiger M; Rummeny E; Braren R
    Magn Reson Med; 2011 Jan; 65(1):229-38. PubMed ID: 20872863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI-Guided Derivation of the Input Function for PET Kinetic Modeling.
    Richard MA; Fouquet JP; Lebel R; Lepage M
    PET Clin; 2016 Apr; 11(2):193-202. PubMed ID: 26952731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of two methods for estimating DCE-MRI parameters via individual and cohort based AIFs in prostate cancer: a step towards practical implementation.
    Fedorov A; Fluckiger J; Ayers GD; Li X; Gupta SN; Tempany C; Mulkern R; Yankeelov TE; Fennessy FM
    Magn Reson Imaging; 2014 May; 32(4):321-9. PubMed ID: 24560287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of DCE-MRI parameters for brain tumors through implementation of physiologically-based pharmacokinetic model approaches for Gd-DOTA.
    Spanakis M; Kontopodis E; Van Cauter S; Sakkalis V; Marias K
    J Pharmacokinet Pharmacodyn; 2016 Oct; 43(5):529-47. PubMed ID: 27647272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncompartmental kinetic analysis of DCE-MRI data from malignant tumors: Application to glioblastoma treated with bevacizumab.
    Port RE; Bernstein LJ; Barboriak DP; Xu L; Roberts TP; van Bruggen N
    Magn Reson Med; 2010 Aug; 64(2):408-17. PubMed ID: 20665785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A general dual-bolus approach for quantitative DCE-MRI.
    Kershaw LE; Cheng HL
    Magn Reson Imaging; 2011 Feb; 29(2):160-6. PubMed ID: 21129878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPU-accelerated nonparametric kinetic analysis of DCE-MRI data from glioblastoma patients treated with bevacizumab.
    Hsu YH; Ferl GZ; Ng CM
    Magn Reson Imaging; 2013 May; 31(4):618-23. PubMed ID: 23200680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An automated method for nonparametric kinetic analysis of clinical DCE-MRI data: application to glioblastoma treated with bevacizumab.
    Ferl GZ; Xu L; Friesenhahn M; Bernstein LJ; Barboriak DP; Port RE
    Magn Reson Med; 2010 May; 63(5):1366-75. PubMed ID: 20432307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic Modeling and Graphical Analysis of 18F-Fluoromethylcholine (FCho), 18F-Fluoroethyltyrosine (FET) and 18F-Fluorodeoxyglucose (FDG) PET for the Fiscrimination between High-Grade Glioma and Radiation Necrosis in Rats.
    Bolcaen J; Lybaert K; Moerman L; Descamps B; Deblaere K; Boterberg T; Kalala JP; Van den Broecke C; De Vos F; Vanhove C; Goethals I
    PLoS One; 2016; 11(8):e0161845. PubMed ID: 27559736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of the pharmacokinetic parameter ratios in DCE-MRI using the reference region model.
    Lee J; Platt S; Kent M; Zhao Q
    Magn Reson Imaging; 2012 Jan; 30(1):26-35. PubMed ID: 22071409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative evaluation of liver function with T1 relaxation time index on Gd-EOB-DTPA-enhanced MRI: comparison with signal intensity-based indices.
    Kamimura K; Fukukura Y; Yoneyama T; Takumi K; Tateyama A; Umanodan A; Shindo T; Kumagae Y; Ueno S; Koriyama C; Nakajo M
    J Magn Reson Imaging; 2014 Oct; 40(4):884-9. PubMed ID: 24677659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying dynamic contrast-enhanced MRI of the knee in children with juvenile rheumatoid arthritis using an arterial input function (AIF) extracted from popliteal artery enhancement, and the effect of the choice of the AIF on the kinetic parameters.
    Workie DW; Dardzinski BJ
    Magn Reson Med; 2005 Sep; 54(3):560-8. PubMed ID: 16088875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.